Example: marketing

FACTSHEET

Patients with aplastic anaemia receiving immuno suppressive therapy with anti-thymocyte globulin (ATG) and/or alemtuzumab (anti-CD52) Factsheet 1, Version 6.1 Issued February 2019

Tags:

  Patients, Factsheet

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries